Loralyn Mears

Director of Scientific Communications at Global Cancer Technology
On the record
Represented by:
Bio

Loralyn is the Director of Scientific Communications for Global Cancer Technology.

Recent Quotes
Sign up to view all
  • Well, glioblastoma is a tortuously difficult disease to treat for a number of reasons. First, it’s very difficult to cross the blood brain barrier. That means you have to have drug particles that are so small that they can be transmitted so that they can be effective in their targeted area in the brain.

    17 September 2021
Employment
Sign up to view all
  • Global Cancer Technology
    Director of Scientific Communications